All Stories

  1. Optimal sequence-based design for multi-antigen HIV-1 vaccines using minimally distant antigens

    Article • PLoS Computational Biology, October 2022, PLOS

    Morgane Rolland

  2. HIV-1 infections with multiple founders associate with the development of neutralization breadth

    Article • PLoS Pathogens, March 2022, PLOS

    Morgane Rolland

  3. Sieve analysis to understand how SARS-CoV-2 diversity can impact vaccine protection

    Article • PLoS Pathogens, March 2021, PLOS

    Morgane Rolland

  4. Factors influencing estimates of HIV-1 infection timing using BEAST

    Article • PLoS Computational Biology, February 2021, PLOS

    Morgane Rolland

  5. RV144 HIV-1 vaccination impacts post-infection antibody responses

    Article • PLoS Pathogens, December 2020, PLOS

    Morgane Rolland

  6. A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants

    Article • Proceedings of the National Academy of Sciences, August 2020, Proceedings of the National Academy of Sciences

    Morgane Rolland

  7. Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand

    Article • PLoS Pathogens, February 2020, PLOS

    Morgane Rolland

  8. The breadth of HIV-1 neutralizing antibodies depends on the conservation of key sites in their epitopes

    Article • PLoS Computational Biology, June 2019, PLOS

    Morgane Rolland

  9. HIV-1 Conserved-Element Vaccines: Relationship between Sequence Conservation and Replicative Capacity

    Article • Journal of Virology, March 2013, ASM Journals

    Morgane Rolland